Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 13, 2022

SELL
$4.58 - $6.8 $1.53 Million - $2.27 Million
-334,000 Closed
0 $0
Q4 2021

Feb 22, 2022

SELL
$5.23 - $7.18 $173 Million - $237 Million
-33,066,000 Reduced 99.0%
334,000 $2.14 Million
Q4 2021

Feb 14, 2022

BUY
$5.23 - $7.18 $175 Million - $240 Million
33,400,000 New
33,400,000 $2.14 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $246M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.